CLINICAL_TRIALS
trial_result
· 2020-12-17
Clinical Trial Update: 8-Week Atopic Dermatitis (AD) Treatment Study [Phase 3]
Summary
Phase 3 clinical trial update for an 8-week atopic dermatitis treatment completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Procter and Gamble | Conditions: Atopic Dermatitis Eczema | Phase 3 | Status: COMPLETED | Results posted: 2020-12-17